Howard D. Homesley
#167,633
Most Influential Person Now
Howard D. Homesley's AcademicInfluence.com Rankings
Howard D. Homesleyphilosophy Degrees
Philosophy
#9940
World Rank
#13572
Historical Rank
Logic
#6892
World Rank
#8450
Historical Rank

Download Badge
Philosophy
Howard D. Homesley's Degrees
- Doctorate Medicine University of California, San Francisco
- PhD Biomedical Sciences University of California, San Francisco
Why Is Howard D. Homesley Influential?
(Suggest an Edit or Addition)Howard D. Homesley's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Incorporation of bevacizumab in the primary treatment of ovarian cancer. (2011) (1942)
- Surgical pathologic spread patterns of endometrial cancer: A gynecologic oncology group study (1987) (1810)
- Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group study (1991) (931)
- Surgical Pathologic Spread Patterns of Endometrial Cancer (2006) (703)
- The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. (1994) (687)
- Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience. (1991) (468)
- Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group. (1999) (439)
- Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer. (1996) (428)
- Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study. (1998) (396)
- Radiation Therapy Versus Pelvic Node Resection for Carcinoma of the Vulva With Positive Groin Nodes (1986) (373)
- Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study. (2004) (347)
- Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study). (1991) (308)
- A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A gynecologic oncology group study (1986) (277)
- Cis‐platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: A phase ii study of the gynecologic oncology group (1981) (270)
- Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study. (2008) (255)
- Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer. (2019) (232)
- A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study. (2009) (212)
- Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: A Gynecologic Oncology Group study. (1999) (212)
- Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: a Gynecologic Oncology Group study. (1995) (205)
- Prognostic factors for groin node metastasis in squamous cell carcinoma of the vulva (a Gynecologic Oncology Group study) (1993) (204)
- Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group Study. (2007) (201)
- Phase III trial of bevacizumab (BEV) in the primary treatment of advanced epithelial ovarian cancer (EOC), primary peritoneal cancer (PPC), or fallopian tube cancer (FTC): A Gynecologic Oncology Group study. (2010) (194)
- Treatment of recurrent or advanced uterine sarcoma. A randomized trial of doxorubicin Versus doxorubicin and cyclophosphamide (a phase III trial of the gynecologic oncology group) (1985) (185)
- Tamoxifen in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study. (2001) (174)
- A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study. (2011) (164)
- Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: a Gynecologic Oncology Group Study. (1990) (159)
- Combined recombinant human interferon alpha2 and cytotoxic agents studied in a clonogenic assay (1985) (152)
- Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a Gynecologic Oncology Group study. (1991) (145)
- Positive groin lymph nodes in superficial squamous cell vulvar cancer. A Gynecologic Oncology Group Study. (1987) (140)
- Radiation Therapy Compared With Pelvic Node Resection for Node-Positive Vulvar Cancer: A Randomized Controlled Trial (2009) (133)
- An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study. (1996) (131)
- Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease. (1992) (129)
- Phase II trial of clsplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: A gynecologic oncology group study (1989) (123)
- Phase II trial of ifosfamide and mesna in advanced ovarian carcinoma: a Gynecologic Oncology Group Study. (1989) (116)
- Cisplatin, vinblastine, and bleomycin in advanced and recurrent ovarian germ-cell tumors. A trial of the Gynecologic Oncology Group. (1989) (112)
- Selective pelvic and periaortic lymphadenectomy does not increase morbidity in surgical staging of endometrial carcinoma. (1992) (109)
- Whole abdominal radiotherapy in the adjuvant treatment of patients with stage III and IV endometrial cancer: a gynecologic oncology group study. (2005) (102)
- Determinants of Survival of Surgically Staged Patients With Endometrial Carcinoma Histologically Confined to the Uterus: Implications for Therapy (1992) (98)
- Chemotherapy of advanced dysgerminoma: trials of the Gynecologic Oncology Group. (1991) (97)
- Adjuvant whole abdominal irradiation in clinical stages I and II papillary serous or clear cell carcinoma of the endometrium: a phase II study of the Gynecologic Oncology Group. (2006) (89)
- Early invasive carcinoma of the cervix (3 to 5 mm invasion): risk factors and prognosis. A Gynecologic Oncology Group study. (1998) (86)
- Binding of specific peroxidase-labeled antibody to placental-type phosphatase on tumor-derived membrane fragments. (1980) (82)
- A dose-escalating study of weekly bolus topotecan in previously treated ovarian cancer patients. (2001) (77)
- Randomized placebo-controlled multicenter evaluation of diethyldithiocarbamate for chemoprotection against cisplatin-induced toxicities. (1995) (76)
- Phase II trial of cisplatin as second‐line chemotherapy in patients with advanced or recurrent endometrial carcinoma A Gynecologic Oncology Group study (1984) (74)
- Cisplatin as initial chemotherapy in ovarian carcinosarcomas: a Gynecologic Oncology Group study. (2004) (73)
- Risk factors for GI adverse events in a phase III randomized trial of bevacizumab in first-line therapy of advanced ovarian cancer: A Gynecologic Oncology Group Study. (2014) (70)
- Patient reported outcomes of a randomized, placebo-controlled trial of bevacizumab in the front-line treatment of ovarian cancer: a Gynecologic Oncology Group Study. (2013) (69)
- cis-Dichlorodiammineplatinum(II) in the treatment of gynecologic malignancies: phase II trials by the Gynecologic Oncology Group. (1979) (69)
- Phase II trial of vinorelbine in recurrent and progressive epithelial ovarian cancer. (1999) (69)
- Reassessment of the surgical scrub. (1978) (67)
- Positive groin lymph nodes in superficial squamous cell vulvar cancer (1987) (65)
- Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: an NRG Oncology/GOG study. (2015) (64)
- Intravenous vincristine infusion: Phase I trial (1981) (60)
- Multidrug Treatment of Advanced and Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study (1984) (58)
- Phase II trial of cisplatin as first‐line chemotherapy in patients with advanced or recurrent endometrial carcinoma: A Gynecologic Oncology Group study (1989) (52)
- Characteristics of patients with small-volume residual ovarian cancer unresponsive to cisplatin-based ip chemotherapy: lessons learned from a Gynecologic Oncology Group phase II trial of ip cisplatin and recombinant alpha-interferon. (1992) (52)
- Management of vulvar cancer (1995) (51)
- Stage II Endometrial Adenocarcinoma: Memorial Hospital for Cancer, 1949-1965 (1977) (50)
- A phase II trial of ifosfamide and mesna in patients with advanced or recurrent mixed mesodermal tumors of the ovary previously treated with platinum-based chemotherapy: a Gynecologic Oncology Group study. (1994) (50)
- Relationship of lesion size to survival in patients with stage IB squamous cell carcinoma of the cervix uteri treated by radiation therapy. (1980) (48)
- Phase II trial of alfimeprase, a novel-acting fibrin degradation agent, for occluded central venous access devices. (2006) (45)
- Steroid receptor concentrations in endometrial carcinoma: effect on survival in surgically staged patients. (1993) (43)
- Intralesional interferon alfa-2b for the treatment of genital warts. (1990) (43)
- A phase I study of weekly cisplatin and whole abdominal radiation for the treatment of stage III and IV endometrial carcinoma: a Gynecologic Oncology Group pilot study. (1996) (43)
- Adriamycin Chemotherapy for Malignant Mixed Mesodermal Tumor of the Ovary A Gynecologic Oncology Group Study (1986) (42)
- Circadian-timed Combination Doxorubicin-cisplatin Chemotherapy for Advanced Endometrial Carcinoma: A Phase Ii Study of the Gynecologic Oncology Group (1993) (42)
- Cisplatin-associated cortical blindness. (1981) (42)
- Rapid escalation of weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease: a Gynecologic Oncology Group study. (1990) (41)
- Endometrial cancer: prognostic factors. (1994) (40)
- Autoimmune hemolytic anemia and ovarian dermoid cysts: Case report and review of the literature (1981) (40)
- Feasibility of laparoscopic management of presumed stage I endometrial carcinoma and assessment of accuracy of myoinvasion estimates by frozen section: a gynecologic oncology group study (2003) (40)
- Phase II study of Ifosfamide and Mesna in refractory adenocarcinoma of the endometrium (1994) (40)
- Prognostic Factors in Surgical Stage III and IV Carcinoma of the Endometrium (1994) (40)
- A Phase II Study of the Efficacy of Recombinant Interferon Gamma in Relapsing Ovarian Adenocarcinoma (1988) (36)
- Phase II clinical study of tamoxifen in advanced endometrial adenocarcinoma: a Gynecologic Oncology Group study. (1984) (35)
- Correlation of female sex steroid hormone receptors with histologic and ultrastructural differentiation in adenocarcinoma of the endometrium (1986) (35)
- Phase II trial of liposomal doxorubicin at 40 mg/m2 every 4 weeks in endometrial carcinoma: A Gynecologic Oncology Group Study (2005) (34)
- Final overall survival (OS) analysis of an international randomized trial evaluating bevacizumab (BEV) in the primary treatment of advanced ovarian cancer: A NRG oncology/Gynecologic Oncology Group (GOG) study. (2018) (34)
- Radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in cervical carcinoma limited to the pelvis: a phase I/II study of the Gynecologic Oncology Group. (2006) (34)
- Phase II trial of cisplatin in advanced or recurrent cancer of the vagina: a Gynecologic Oncology Group Study. (1986) (34)
- Intraperitoneal administration of cisplatin and 5-fluorouracil in residual ovarian cancer: a Phase II Gynecologic Oncology Group trial. (1995) (32)
- Single-agent therapy for nonmetastatic and low-risk gestational trophoblastic disease. (1998) (32)
- Gynecologic Oncology Group experience with ifosfamide. (1990) (32)
- Patient-reported peripheral neuropathy of doxorubicin and cisplatin with and without paclitaxel in the treatment of advanced endometrial cancer: Results from GOG 184. (2010) (31)
- Antiestrogenic Potency of Toremifene and Tamoxifen in Postmenopausal Women (1993) (30)
- Correlation of pretreatment drug induced apoptosis in ovarian cancer cells with patient survival and clinical response (2012) (28)
- Cisplatin, vinblastine, and bleomycin in advanced and recurrent ovarian germ‐cell tumors. A trial of the Gynecologic Oncology Group (1990) (28)
- Analysis of the relationships of the ploidy and cell cycle kinetics to differentiation and the female sex steroid hormone receptors in adenocarcinoma of the endometrium. (1986) (27)
- Cancers of the uterine cervix and endometrium: major issues and future research directions. (1994) (26)
- Phase II trials of cisplatin and piperazinedione in advanced or recurrent squamous cell carcinoma of the vulva: a Gynecologic Oncology Group Study. (1986) (26)
- Cis‐platinum in the treatment of advanced or recurrent adenocarcinoma of the ovary: A phase II study of the Gynecologic Oncology Group (1983) (25)
- Phase II experience with ifosfamide/mesna in gynecologic malignancies: preliminary report of Gynecologic Oncology Group studies. (1989) (25)
- Phase III trial of induction gemcitabine or paclitaxel plus carboplatin followed by paclitaxel consolidation in ovarian cancer. (2011) (25)
- In vitro chemotherapy testing of gynecologic tumors: basis for planning therapy? (1983) (24)
- Randomized Comparison of Cisplatin plus Epirubicin or Doxorubicin for Advanced Epithelial Ovarian Carcinoma: A Multicenter Trial (1992) (24)
- Development of single-agent chemotherapy regimens for gestational trophoblastic disease. (1994) (23)
- Is Hysterectomy a Risk Factor for Vaginal Cancer (1986) (23)
- Therapy of stage III (optimal) epithelial carcinoma of the ovary with melphalan or melphalan plus corynebacterium parvum (a gynecologic oncology group study) (1986) (21)
- Umbilical metastasis from gynecologic malignancies: a primary carcinoma of the fallopian tube. (1981) (20)
- A phase II study of paclitaxel for the treatment of ovarian stromal tumors: An NRG Oncology/ Gynecologic Oncology Group Study. (2016) (20)
- Identification of Antigenic Components Recognized by “Membrane‐Bound” Antibodies From Ovarian Cancer Patients (1984) (20)
- Total hip arthroplasty revision: a decade of change. (2004) (20)
- A phase II trial of weekly 1-hour paclitaxel as second-line therapy for endometrial and cervical cancer (2008) (19)
- Neoadjuvant therapy for advanced squamous cell carcinoma of the cervix: cisplatin followed by radiation therapy--a pilot study of the Gynecologic Oncology Group. (1987) (19)
- Ovarian germ cell tumors: Adjuvant trials of the Gynecologic Oncology Group (GOG) (1989) (19)
- A phase I study of weekly topotecan and Paclitaxel in previously treated epithelial ovarian carcinoma patients. (2002) (18)
- The microculture-kinetic (MiCK) assay: the role of a drug-induced apoptosis assay in drug development and clinical care. (2012) (18)
- Results of revision total knee arthroplasty after exposure of the knee with extensor mechanism tenolysis. (2004) (18)
- Successful treatment of pseudomyxoma peritonei of ovarian origin with cis-platinum, doxorubicin, and cyclophosphamide. (1985) (18)
- Second-look laparotomy in the patient with minimal residual stage III ovarian cancer (a Gynecologic Oncology Group Study). (1989) (18)
- Management of endometrial cancer. (1996) (17)
- Phase II trial of piperazinedione in patients with advanced or recurrent uterine sarcoma: A Gynecologic Oncology Group study (1985) (17)
- Lymph node findings and outcome in squamous cell carcinoma of the vulva (1994) (17)
- Chemotherapy, early surgical reassessment, and hyperfractionated abdominal radiotherapy in stage III ovarian cancer: results of a gynecologic oncology group study. (1996) (17)
- Revised 1988 International Federation of Gynecology and Obstetrics Staging Systems for Endometrial and Vulvar Cancer: An Assessment (1992) (16)
- Endometrial carcinoma in vitro chemosensitivity testing of single and combination chemotherapy regimens using the novel microculture kinetic apoptosis assay: implications for endometrial cancer treatment. (2010) (16)
- Vincristine infusion in refractory gynecologic malignancies. (1986) (16)
- Serological response patterns to herpes virus type 2 early and late antigens in cervical carcinoma patients. (1979) (15)
- A phase II trial of didemnin B (NSC #335319) in patients with advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group Study. (1996) (15)
- A Phase II Trial of Gallium Nitrate (NSC #15200) in Nonsquamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study (1995) (14)
- Hexamethylmelamine as first-line chemotherapy in the treatment of advanced or recurrent carcinoma of the endometrium: A phase II trial of the Gynecologic Oncology Group (1988) (13)
- Comparison of Cryosurgery and Carbon Dioxide Laser Ablation for Treatment of Cervical Intraepithelial Neoplasia (1985) (13)
- Tomudex (ZD1694, NSC 639186) in platinum-pretreated recurrent epithelial ovarian cancer: a phase II study by the Gynecologic Oncology Group (1998) (12)
- Phase II trial of etoposide in the management of advanced or recurrent non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. (1984) (12)
- Adverse effects of intraperitoneal fluorouracil in patients with optimal residual ovarian cancer after second-look laparotomy: a Gynecologic Oncology Group Study. (1989) (12)
- Placental‐Type Alkaline Phosphatase in Ovarian Cancer Fluids and Tissues (1984) (11)
- Gynecologic Oncology Group studies with ifosfamide. (1992) (11)
- Present status and future direction of clinical trials in advanced endometrial carcinoma. (2008) (11)
- Early Invasive Carcinoma of the Cervix (3− to 5-mm Invasion): Risk Factors and Prognosis (1998) (11)
- Hazards of central venous pressure monitoring: pericardial tamponade. (1971) (11)
- Chemotherapy of advanced squamous carcinoma of the cervix: A phase I‐II study of high‐dose cisplatin and cyclophosphamide A pilot study of the Gynecologic Oncology Group (1984) (10)
- Prospective investigation of risk factors for gastrointestinal adverse events in a phase III randomized trial of bevacizumab in first-line therapy of advanced epithelial ovarian cancer, primary peritoneal cancer or fallopian tube cancer: A Gynecologic Oncology Group study (2011) (10)
- Combined interferon alf a and doxorubicin in the treatment of advanced cervical cancer (1991) (10)
- Radiation-induced vesicosacral fistula: treatment with continent urinary diversion. (1995) (9)
- Phase 1 trial of intraperitoneal AD-32 in gynecologic malignancies. (1996) (9)
- ICRF‐159 (Razoxane) in Patients with Advanced Adenocarcinoma of the Endometrium A Gynecologic Oncology Group Study (1986) (9)
- Phase II trial of liposomal doxorubicin at 40 mg/m(2) every 4 weeks in endometrial carcinoma: a Gynecologic Oncology Group Study. (2005) (9)
- Recurrence in endometrial carcinoma as a function of extended surgical staging data (1984) (9)
- Phase I trials of high-dose cytosine arabinoside (HDara-C) and HDara-C plus cisplatin in patients with advanced malignancies. (1985) (9)
- Phase II Trial of Piperazinedione in the Treatment of Advanced or Recurrent Endometrial Carcinoma A Gynecologic Oncology Group Study (1986) (9)
- Single dose carbenicillin versus T-tube drainage in patients undergoing vaginal hysterectomy. (1981) (9)
- Use of the Human Tumor Stem Cell Assay to Study Chemotherapy Sensitivity in Cancer of the Cervix (1984) (9)
- Autologous antibodies eluted from membrane fragments isolated from the effusions of human ovarian epithelial neoplasms. I. Quantitation of antibodies. (1985) (9)
- Localized ovarian cancer in the elderly: The gynecologic oncology group experience (2010) (9)
- A phase I trial of recombinant leukocyte alpha 2 interferon in patients with advanced malignancy. (1985) (8)
- Cisplatin, Vinblastine, and Bleomycin in Advanced and Recurrent Ovarian Germ-Cell Tumors: A Trial of the Gynecologic Oncology Group (1990) (8)
- Use of colposcopically directed, four-quadrant cervical biopsy by the colposcopy trainee. (1984) (8)
- Embryonal Rhabdomyosarcoma: Adjuvant and Ex Vivo Assay-Directed Chemotherapy (2009) (7)
- Hazards of central venous pressure monitoring: pericardial tamponade. (1972) (7)
- Rapid escalation of weekly intramuscular methotrexate for nommetastatic gestational trophoblastic disease: A gynecologic oncology group study (1991) (7)
- Aminothiadiazole (NSC #4728) in Patients With Advanced Cervical Carcinoma A Phase II Study of the Gynecologic Oncology Group (1987) (7)
- The addition of paclitaxel to doxorubicin and cisplatin and volume-directed radiation does not improve overall survival (OS) or long-term recurrence-free survival (RFS) in advanced endometrial cancer (EC): A randomized phase III NRG/Gynecologic Oncology Group (GOG) study. (2019) (7)
- CISPLATIN IN THE TREATMENT OF ADVANCED OR RECURRENT CERVIX AND UTERINE CANCER (1980) (7)
- Phase I study of N-(phosphonacetyl)-L-aspartate with fluorouracil and with or without dipyridamole in patients with advanced cancer. (1996) (6)
- Treatment of Adenocarcinoma of the Endometrium at Memorial-James Ewing Hospitals, 1949-1965 (1976) (6)
- Menstrual Dysfunction Following Use of Oral Contraceptives (1970) (6)
- Chemotherapy of advanced ovarian epithelial carcinoma with melphalan and levamisole: a pilot study of the Gynecologic Oncology Group. (1981) (6)
- Early phase II Gynecologic Oncology Group experience with ifosfamide/mesna in gynecologic malignancies (2004) (6)
- Evaluating the acquisition of colposcopy skills in an obstetric-gynecologic residency program. (1985) (6)
- Therapy of stage III (optimal) epithelial carcinoma of the ovary with melphalan or melphalan plus Corynebacterium parvum (a Gynecologic Oncology Group Study). (1987) (6)
- Phase II study of Baker's antifol (triazinate, TZT, NSC-139,105) in advanced squamous cell carcinoma of cervix. (1982) (6)
- Is hysterectomy a risk factor for vaginal cancer? (1987) (5)
- Phase II trial of AMSA in patients with advanced or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study. (1983) (5)
- Concurrent chemotherapy and single high-dose plus whole abdominopelvic radiation for persistent ovarian carcinoma. (1989) (5)
- In vitro growth characteristics and chemosensitivities of endometrial cancer using a soft agar clonogenic assay (1987) (5)
- Positive groin lymph nodes in vulvar cancer with superficial tumor penetration (1984) (4)
- ICRF‐159 (Razoxane) in Patients with Advanced Nonsquamous Cell Carcinoma of the Cervix A Gynecologic Oncology Group Study (1986) (4)
- Gynecologic problems in older women. (1998) (4)
- Low-Dose Carbenicillin Prophylaxis for Vaginal and Abdominal Hysterectomy (1978) (4)
- Can we increase response rate (RR) and overall survival (OS) by individualizing chemotherapy in ovarian cancer (OC): The role of a new chemotherapy (CT) induced apoptosis assay. (2010) (4)
- Mitoxantrone in the treatment of advanced non-squamous carcinoma of the cervix (A phase II trial of the gynecologic oncology group) (2004) (4)
- Phase II trial of piperazinedione (NCS 135758) in the treatment of advanced or recurrent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study (1983) (4)
- Ascites predicts degree of treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube, and peritoneal cancers (2014) (4)
- Quality of Life Outcomes of a Randomized, Placebo-Controlled Trial of Bevacizumab in the Front-Line Treatment of Ovarian Cancer: a Gynecologic Oncology Group Study (2011) (4)
- Hexamethylmelamine as first‐line chemotherapy in the treatment of advanced or recurrent carcinoma of the endometrium: A phase II trial of the Gynecologic Oncology Group (1989) (4)
- Cisplatin‐ based chemotherapy of epithelial ovarian cancer (1989) (3)
- Phase II trial of dichloromethotrexate in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study. (1987) (3)
- Treatment of ovarian germ cell tumors with cisplatin + vinblastine + bleomycin: Longterm results of therapy (1984) (3)
- A phase II trial of weekly one hour paclitaxel as second-line therapy for endometrial and cervical cancer. (2006) (3)
- Endometrial carcinoma in-vitro chemosensitivity testing of single and combination chemotherapy regimens using the novel microculture kinetic (MICK) apoptosis assay: Implications for endometrial cancer treatment (2010) (3)
- Phase 2 trial of moderately high dose single agent mitoxantrone in platinum and paclitaxel-refractory ovarian cancer. (1998) (3)
- Evaluation of the abnormal Pap smear. (1977) (3)
- Phase II trial of piperazinedione (NSC 135758) in the treatment of advanced or recurrent carcinoma of the ovary A Gynecologic Oncology Group study (1984) (3)
- Autologous antibodies eluted from membrane fragments isolated from the effusions of human ovarian epithelial neoplasms (1985) (3)
- Treatment of Vaginal Intraepithelial Neoplasia With the Carbon Dioxide Laser (1983) (3)
- Observations on bladder function following radical hysterectomy using carbon dioxide cystometry. (1978) (3)
- Phase II clinical trial of diaziquone in the treatment of patients with epithelial ovarian cancer: a Gynecologic Oncology Group Study. (1986) (3)
- Ineffectiveness of povidone-iodine irrigation of abdominal incisions. (1980) (3)
- Safety and Efficacy of Alfimeprase for Restoring Function in Occluded Central Venous Catheters: Interim Results of a Phase 2, Multicenter, Randomized, Double-Blind Study (NuCath). (2004) (3)
- Incisional recurrence of carcinoma. (1982) (2)
- Staging and current treatments for endometrial cancer. (1987) (2)
- Phase II evaluation of dianhydrogalactitol in the treatment of advanced non-squamous cervical carcinoma (2004) (2)
- Leukemogenesis related to chemotherapy of ovarian carcinoma: a review with three new case reports. (1984) (2)
- Morphine: immediate release vs. controlled release. (1989) (2)
- Phase II trial of razoxane in the management of recurrent adenocarcinoma of the ovary: a Gynecologic Oncology Group study. (1984) (2)
- Single agent weekly methotrexate (MTX) therapy in the treatment of nonmetastatic gestational trophoblastic disease (NMGTD) (1987) (2)
- Randomized study of radiation therapy (Regimen I=Reg. I) versus pelvic node resection (Regimen II=Reg. II) for patients with invasive squamous cell carcinoma of the vulva having positive groin nodes (1985) (2)
- Comparison of heparin and intermittent calf compression for prevention of pulmonary embolism (1983) (1)
- Combined interferon alfa and doxorubicin in the treatment of advanced cervical cancer. (1991) (1)
- Phase II trial of liposomal doxorubicinin disseminated endometrial carcinoma: A Gynecologic Oncology Group study (2005) (1)
- Phase II study of Baker's antifol (triazinate, TZT, NSC 139, 105) in advanced carcinoma of the ovary (2004) (1)
- Normal and neoplastic tissue effects of high intensity intracavitary irradiation: cancer of the corpus uteri. (1974) (1)
- Chemotherapy of advanced carcinoma of the cervix with cyclophosphamide and cisplatin. A pilot study of the gynecologic oncology group (1981) (1)
- Assessment of Colposcopic Skills (1987) (1)
- Concurrent chemotherapy and single high‐dose plus whole abdominopelvic radiation for persistent ovarian carcinoma (1990) (1)
- Phase II trial of menogaril (NSC 269148) in chemotherapy-naive patients with advanced squamous carcinoma of the cervix (1992) (1)
- Combined antiproliferative activity of 5-fluorouracil and mitomycin-C against primary human ovarian tumors and cell lines in a clonogenic assay. (1993) (1)
- An in vitro thymidine incorporation assay for human cancers: technical details revisited. (1992) (1)
- A748 MULTICENTER, DOUBLE-BLIND, RANDOMIZED COMPARISON OF ORAL TRANSMUCOSAL FENTANYL CITRATE (OTFC) VS. PLACEBO IN CANCER PATIENTS WITH BREAKTHROUGH PAIN (1997) (1)
- Vincristine, cyclophosphamide, and adriamycin in advanced ovarian cancer (1978) (0)
- Lethal peritonitis following internal small bowel herniation and infarction after use of a simplified stapler colostomy technique. (1980) (0)
- Book ReviewPractical Gynecologic Surgery: Principles in Practice (1990) (0)
- Proliferating Brenner tumor. (1977) (0)
- Performance of a biomarker panel to identify malignancy within a pelvic mass population. (2009) (0)
- Role of chemotherapy dose intensification in the treatment of advanced ovarian cancer. Commentaries (1995) (0)
- Carcinoma of the Cervix Complicated by a Soup Spoon (1978) (0)
- Specificity and activity of autologous antibodies eluted from membrane fragments isolated from human ovarian epithelial neoplastic effusions (1985) (0)
- [Vulvar cancer]. (1986) (0)
- Dose intensity study of weekly intramuscular methotrexate (WIM) for nonmetastatic gestational trophoblastic disease (NGTD) (a Gynecologic Oncology Group (GOG) study) (1989) (0)
- Commentary (Homesley/Muss): Role of Chemotherapy Dose Intensification in the Treatment of Advanced Ovarian Cancer (1995) (0)
- Phase II study of Baker's antifol (triazinate, TZT, NSC 139, 105) in advanced carcinoma of the ovary. A Gynecologic Oncology Group study. (1983) (0)
- Book Review Textbook of Gynecologic Oncology Edited by G.R.P. Blackledge, J.A. Jordan, and H.M. Shingleton. 504 pp., illustrated. Philadelphia, W.B. Saunders, 1991. $60. (1991) (0)
- Screening for cervical cancer: 1982--an update. (1982) (0)
- Combined Therapy in Uterine Cancer: Future Directions (2005) (0)
- Phase II trial of ifosfamide and mesna in refractory epithelial ovarian carcinoma (1989) (0)
- Is there a "best time" for postpartum vaginal hysterectomy? (1972) (0)
- Malignant ovarian tumors simulating hydatidiform mole on ultrasound (1982) (0)
- Book ReviewGynecologic Oncology (1986) (0)
- Patient Characteristics and Outcomes for Locally Advanced Cervical Cancer in Minority and Underserved Populations in Eastern North Carolina (2007) (0)
- Part 2 of 12 : Case Studies in Recurrent Gynecologic and Lung Cancer : Chemotherapeutic Innovations Watch Your (0)
- Characteristics of Patients With Small-Volume Residual Ovarian Cancer Unresponsive to Cisplatin-Based Intraperitoneal Chemotherapy: Lessons Learned from a Gynecologic Oncology Group Phase II Trial of Interperitoneal Cisplatin and Recombinant α-Interferon (1992) (0)
- Carcinoma of the endometrium : issues of the 1990s (1994) (0)
- Correlation of pretreatment drug induced apoptosis in ovarian cancer cells with patient survival and clinical response (2012) (0)
- Phase II evaluation of dianhydrogalactitol in the treatment of advanced non-squamous cervical carcinoma. A Gynecologic Oncology Group study. (1984) (0)
- A phase I trial of recombinant leukocyte α2 interferon in patients with advanced malignancy (1985) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Howard D. Homesley?
Howard D. Homesley is affiliated with the following schools: